Nucleic Acid Therapeutics CDMO Market
Nucleic Acid Therapeutics CDMO Market Research Report By Technology (Gene Editing, Gene Therapy, RNA Interference, CRISPR-Cas9, Antisense Oligonucleotides), By Product Type (Plasmid DNA, mRNA, siRNA, Antisense Oligonucleotides, Gene Therapy Vectors), By Application (Oncology, Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders), By End User (Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Academic Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032
Nucleic Acid Therapeutics CDMO Market Overview
As per MRFR analysis, the nucleic acid therapeutics CDMO market size was estimated at 5.66 (USD billion) in 2022.
ย The nucleic acid therapeutics CDMO market is expected to grow from 6.35 (USD billion..